Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL CHEMIC Plunges 7%; BSE HEALTHCARE Index Up 0.3%
Thu, 1 Aug 15:47

HIKAL CHEMIC Plunges 7%; BSE HEALTHCARE Index Up 0.3%Image source: Sakorn BernardaSv/www.istockphoto.com

HIKAL CHEMIC share price has plunged 7% and is presently trading at Rs 337.9.

Meanwhile, the BSE HEALTHCARE index is at 40,635.2 (up 0.3%).

Among the top losers in the BSE HEALTHCARE index today are LAURUS LABS (down 2.6%) and Glenmark Pharma (down 1.8%).

Jubilant Pharmova (up 11.6%) and ASTER DM HEALTHCARE (up 6.3%) are among the top gainers today.

Over the last one year, HIKAL CHEMIC has moved up from Rs 283.8 to Rs 337.9, registering a gain of Rs 54.1 (up 19.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,736.5 to 40,635.2, registering a gain of 46.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 128.9%), SUVEN PHARMACEUTICALS (up 102.2%) and Lupin (up 98.2%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,867.6 (up 0.2%).

The top gainers among the BSE Sensex today are Power Grid Corp. (up 3.8%) and HDFC Bank (up 1.9%). The most traded stocks in the BSE Sensex are Tata Steel and Power Grid Corp..

In the meantime, NSE Nifty is at 25,006.0 (up 0.2%). Power Grid Corp. and Coal India are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,527.7 to 81,867.6, registering a gain of 15,339.9 points (up 23.1%).

HIKAL CHEMIC Financial Update...

HIKAL CHEMIC net profit fell 5.6% YoY to Rs 340 million for the quarter ended March 2024, compared to a profit of Rs 360 million a year ago. Net sales declined 5.7% to Rs 5,141 million during the period as against Rs 5,453 million in January-March 2023.

For the year ended March 2023, HIKAL CHEMIC reported 51.2% decrease in net profit to Rs 784 million compared to net profit of Rs 1,605 million during FY22. Revenue of the company grew 4.1% to Rs 20,230 million during FY23.

The current Price to earnings ratio of HIKAL CHEMIC, based on rolling 12 month earnings, stands at 59.9.


Equitymaster requests your view! Post a comment on "HIKAL CHEMIC Plunges 7%; BSE HEALTHCARE Index Up 0.3%". Click here!